GenoMed4All and SYNTHEMA were represented at this year’s ASCAT conference thanks to our colleagues at ERN-EuroBloodNet. Healthcare professionals, researchers and patient groups have gathered this week at the 19th Annual Scientific Conference in London, hosted by the Academy For Sickle Cell & Thalassaemia (ASCAT) in collaboration with British Society for Haematology and European Hematology Association (EHA).
The aim? To explore the latest breakthroughs in haemoglobinopathies and discuss the new advancements in diagnosis, treatment and emerging therapies for Sickle Cell Disease (SCD) and Thalassemia.
During the Patient Session on the 2nd day of the conference, Mariangela Pellegrini from ERN-EuroBloodNet highlighted the work we’ve been doing collaboratively with them and our sister project SYNTHEMA to advance hashtag precision medicine for SCD.
